1-3 of 3
Thomas Bauknecht
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

An Integrated Clinical-Genomics Approach Identifies a Candidate Multi-Analyte Blood Test for Serous Ovarian Carcinoma

Available to Purchase
Ivo Meinhold-Heerlein, Dirk Bauerschlag, Yingyao Zhou, Lisa M. Sapinoso, Keith Ching, Henry Frierson, Jr., Karen Bräutigam, Jalid Sehouli, Elmar Stickeler, Dominique Könsgen, Felix Hilpert, Constantin S. von Kaisenberg, Jacobus Pfisterer, Thomas Bauknecht, Walter Jonat, Norbert Arnold, Garret M. Hampton
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (2): 458–466.
https://doi.org/10.1158/1078-0432.CCR-06-0691
Published: 25 January 2007
View articletitled, An Integrated Clinical-Genomics Approach Identifies a Candidate Multi-Analyte Blood Test for Serous Ovarian Carcinoma
Open the PDF for An Integrated Clinical-Genomics Approach Identifies a Candidate Multi-Analyte Blood Test for Serous Ovarian Carcinoma in another window
Includes: Supplementary data
Journal Articles

Safety and Immunogenicity of TA-HPV, a Recombinant Vaccinia Virus Expressing Modified Human Papillomavirus (HPV)-16 and HPV-18 E6 and E7 Genes, in Women with Progressive Cervical Cancer

Available to Purchase
Andreas M. Kaufmann, Peter L. Stern, Elaine M. Rankin, Harald Sommer, Volkmar Nuessler, Achim Schneider, Malcom Adams, Toli S. Onon, Thomas Bauknecht, Uwe Wagner, Karlijn Kroon, Julian Hickling, Christopher M. Boswell, Simon N. Stacey, Henry C. Kitchener, Jennifer Gillard, Jantien Wanders, John St. C. Roberts, Heinz Zwierzina
Journal: Clinical Cancer Research
Clin Cancer Res (2002) 8 (12): 3676–3685.
Published: 01 December 2002
View articletitled, Safety and Immunogenicity of TA-HPV, a Recombinant Vaccinia Virus Expressing Modified Human Papillomavirus (HPV)-16 and HPV-18 E6 and E7 Genes, in Women with Progressive Cervical Cancer
Open the PDF for Safety and Immunogenicity of TA-HPV, a Recombinant Vaccinia Virus Expressing Modified Human Papillomavirus (HPV)-16 and HPV-18 E6 and E7 Genes, in Women with Progressive Cervical Cancer in another window
Journal Articles

Immunological Consolidation of Ovarian Carcinoma Recurrences with Monoclonal Anti-Idiotype Antibody ACA125: Immune Responses and Survival in Palliative Treatment: See The Biology Behind: K. A. Foon and M. Bhattacharya-Chatterjee, Are Solid Tumor Anti-Idiotype Vaccines Ready for Prime Time? Clin. Cancer Res., 7:1112–1115, 2001.

Available to Purchase
Uwe Wagner, Siegmund Köhler, Silke Reinartz, Patrick Giffels, Jens Huober, Kirsten Renke, Harald Schlebusch, Hans-Jürgen Biersack, Volker Möbus, Rolf Kreienberg, Thomas Bauknecht, Dieter Krebs, Diethelm Wallwiener
Journal: Clinical Cancer Research
Clin Cancer Res (2001) 7 (5): 1154–1162.
Published: 01 May 2001
View articletitled, Immunological Consolidation of Ovarian Carcinoma Recurrences with Monoclonal Anti-Idiotype Antibody ACA125: Immune Responses and Survival in Palliative Treatment: See The Biology Behind: K. A. Foon and M. Bhattacharya-Chatterjee, Are Solid Tumor Anti-Idiotype Vaccines Ready for Prime Time? Clin. Cancer Res., 7:1112–1115, 2001.
Open the PDF for Immunological Consolidation of Ovarian Carcinoma Recurrences with Monoclonal Anti-Idiotype Antibody ACA125: Immune Responses and Survival in Palliative Treatment: See The Biology Behind: K. A. Foon and M. Bhattacharya-Chatterjee, Are Solid Tumor Anti-Idiotype Vaccines Ready for Prime Time? Clin. Cancer Res., 7:1112–1115, 2001. in another window